ADPT vs SOFI · rev $142.4M vs P/E 39, rev $283.1M
Adaptive Biotechnologies Corp (ADPT) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Latest reported SOFI revenue for 2026-06-30 was $283.1M. Net income was $323.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
ADPT currently screens at market cap $2.69B. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the ADPT and SOFI stock pages for the full models.
Not investment advice.